Our Vision

Synthetic Biology Innovation Cluster

What is the Synthetic Biology Innovation Cluster?

 

Founded at the Impact Centre in 2013, the Synthetic Biology Innovation Cluster is a collective network of scientific researchers and private sector industry leaders. Synthetic Biology Innovation Cluster (SynBio-IC) plays a key role in forming partnerships to innovate new solutions for markets worldwide— bringing together researchers, government agencies and industry partners to unlock the full potential of synthetic biology. The SynBio-IC recognizes the need for co-operation between researchers and industry leaders is essential in accelerating the translation of new knowledge into commercially viable and socially relevant products. In order to foster these partnerships, gatherings are based across Southern Ontario where these partnerships are formed and strengthened further, in order to continuously push the limits of synthetic biology.

 
 

Cluster Contacts

 

Stanley Wong joined the Impact Centre in 2013 as the lead staff scientist in the area of synthetic biology. He manages the Impact Centre’s Synthetic Biology Innovation Cluster where he helps facilitate academic-industry collaborations, communicate with relevant partners including governmental agencies, and writes grant proposals. Stanley received his BASc and PhD in biomedical engineering from the University of Toronto. His studies mainly focused on the development of protein based biosensor tools to help elucidate the inner workings of cells. Stanley has an interest in designing and developing technology and products by applying fundamental science and engineering principles.

 
David McMillen is a Professor in the Department of Chemical and Physical Sciences at the University of Toronto Mississauga. His research combines experimental and theoretical techniques to study the internal dynamics of cells. Professor McMillen is interested in the potential of synthetic biology to address real-world issues. Examples of applied projects include efforts at developing systems to: detect disease microorganisms and respond to counter them; create robust microorganism-based biosensors for blood assays; and engineer metabolic pathways for better production of useful biological products.